Bookmark

Add to MyYahoo RSS

Pharmaceutical News

Pharmaceuticals news continually updated from thousands of sources around the net.

3 hrs ago | GuruFocus.com

Vanguard Health Care Fund's Top Second Quarter Stocks

Over the duration of the second quarter the Vanguard Health Care Fund purchased added four new stocks to its holdings.

Comment?

Related Topix: Financial Markets, Biotech, Merck , Medicine, Healthcare Industry, Bloomsbury Publishing, Bristol Myers Squibb, Publishing, Media, Bristol-Myers Squibb

5 hrs ago | Drug Researcher

I'm sticking with you: McKesson and CVS JV solid for 3 more years

McKesson Corporation, a healthcare services and information technology company, today announced a three-year extension to its pharmaceutical distribution agreement with CVS Caremark.

Comment?

Related Topix: Retail, CVS, Biotech, Medicine, McKesson, Household Products, Healthcare Industry, CVS Caremark, Cardinal Health

8 hrs ago | Business Wire

McKesson Announces Preliminary Voting Results from 2014 Annual Stockholder Meeting

All Board members were reelected and all Board vote recommendations were upheld.

Comment?

Related Topix: Biotech, Medicine, McKesson, Household Products, Healthcare Industry, Symphony Technology Group, Star Analytics, Startups, Horizon Software International, Paragon Software

8 hrs ago | The Daily Caller

Selena Gomez Shows Off Skin In Snakeskin Halter Top

The movie, which has the same producer as the 1999 classic "Ten Things I Hate About You," premieres Aug. 1. Meanwhile, Justin Bieber was getting swung on by Orlando Bloom .

Comment?

Related Topix: Charitable Organizations, American Cancer Society, Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Healthcare Industry

8 hrs ago | Forbes.com

Teva Pharmaceutical Industries EPS Estimates Improved In Past Month

Leading up to Teva Pharmaceutical Industries' announcement of its second-quarter earnings on Thursday, July 31, 2014, analysts have become more bullish as expectations have improved over the past month from $1.17 per share to the current projection of earnings of $1.22 per share.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Cephalon, Healthcare Industry, Financial Markets

12 hrs ago | Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

"We have a long t... )--Jamba Inc., a leading healthy active lifestyle brand and the leading retailer of freshly squeezed juice today announced that consumers who visit J... )--Tigermed and Frontage complete strategic investment agreement.

Comment?

Related Topix: Fiserv, Financial Services, Computers, Biotech, Medicine, McKesson, Household Products, Healthcare Industry, Retail, CVS Caremark, CVS, Jamba, Activision, Video Games, Software

17 hrs ago | Bloomberg

Bayer Second-Quarter Earnings Rise on Sales of New Drugs

Bayer AG 's second-quarter earnings rose 1 percent as growth in new medicines offset the effect of a strengthening euro on margins at the German company's crop and plastics units.

Comment?

Related Topix: Manufacturing, Bayer AG, Biotech, Chemicals, e-Spirit, World News, Germany

Tue Jul 29, 2014

Customer Interaction Solutions

Investor Alert: Investigation of Impax Laboratories, Inc. Announced by Glancy Binkow & Goldberg LLP

Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Impax Laboratories, Inc .

Comment?

Related Topix: Biotech, Impax Laboratories, Medicine, Healthcare Industry, Startups

WBTV

UNC to get 2nd generation of Spangler oversight

North Carolina lawmakers are adding the daughter of billionaire C.D. Spangler to the board overseeing the state's 17-campus public university system.

Comment?

Related Topix: North Carolina

Pharmaceutical Processing

Impax Labs Shares Slump after FDA Inspection

Shares of Impax Labs sank Tuesday after an FDA inspection uncovered potential problems at a facility where the company will make its experimental Parkinson's disease drug Rytary.

Comment?

Related Topix: Biotech, Impax Laboratories, Medicine, Healthcare Industry, Food and Drug Administration

Pharmaceutical Processing

European Commission Approves Eliquis for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism

Bristol-Myers Squibb and Pfizer announced that the European Commission has approved Eliquis for the treatment of DVT and PE, and the prevention of recurrent DVT and PE in adults.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Healthcare Industry, Pfizer

Reuters

U.S. FDA raises concerns about Impax's Taiwanese plant

Impax Laboratories Inc said the U.S. Food and Drug Administration issued "certain observations" after an inspection of the company's manufacturing plant in Taiwan.

Comment?

Related Topix: Biotech, Impax Laboratories, Food and Drug Administration, Medicine, Healthcare Industry, Startups

TheCourier.com

Speedway to expand offices

By LOU WILIN STAFF WRITER Speedway plans to invest $9.1 million, buying a building in Springfield and renovating part of its nearby Enon headquarters to add 350 jobs and retain 800 employees, the company reported.

Comment?

Related Topix: Springfield, OH, Enon, OH, Clark County, OH, Biotech, Cardinal Health, Medicine, Healthcare Industry

Mon Jul 28, 2014

AmericanBankingNews.com

Telit Communications Plc Receives "Buy" Rating from Canaccord Genuity

's stock had its "buy" rating restated by analysts at Canaccord Genuity in a research report issued to clients and investors on Monday.

Comment?

Related Topix: Tongjitang Chinese Medicines

Pharmaceutical Technology

Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies

Bristol-Myers Squibb and Ono Pharmaceutical signed a collaboration agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens to help address the unmet medical needs of patients with cancer in Japan, South Korea, and Taiwan.

Comment?

Related Topix: Bloomsbury Publishing, Biotech, Bristol Myers Squibb, Publishing, Media, Medarex, Medicine, Bristol-Myers Squibb, Healthcare Industry, Health, Lung Cancer

Seeking Alpha

Investors Should Screen Out Lantheus IPO

LNTH, a developer and distributor of imaging agents used in medical diagnostics, plans to raise $125.0 million in its upcoming IPO.

Comment?

Related Topix: North Billerica, MA, Billerica, MA, Heart Failure, Health, Biotech, Medicine, Healthcare Industry, Cardinal Health, Johnson and Johnson

Sys-Con Media

In-Vitro Toxicology/Toxicity Testing (Cell Culture, HTS, Omics) Market - Global Forecasts to 2018

The global market of in-vitro toxicology testing is subdivided into industry, technology, method, application and geography.

Comment?

Sun Jul 27, 2014

OpEdNews

Chiding CEOs, At Walgreens & Other Corporate Defectors

Will Walgreens move headquarters from Illinois to Switzerland? Walgreens could avoid paying $4 billion in U.S. taxes Walgreens is the pharmacy that, at least according to its website, can be found "at the corner of Happy & Healthy."

Comment?

Related Topix: US News, US Senate, US Politics, Senator Dick Durbin, Switzerland, World News, Deerfield, IL, Biotech, Medicine, Mylan Laboratories, Healthcare Industry, Democrat, Senator Joe Manchin

Sat Jul 26, 2014

CNN

A World Without AIDS

I think we figured out the easy part, which is finding the cure to AIDS. But now we will be faced with another challenge.

Comment?

Related Topix: Bill Gates, Bill and Melinda Gates Foundation, Charitable Organizations

AmericanBankingNews.com

Mylan Lowered to Neutral at Citigroup Inc.

They currently have a $57.00 price objective on the stock, down from their previous price objective of $61.00.

Comment?

Related Topix: Biotech, Medicine, Mylan Laboratories, Healthcare Industry, Dey, Startups, Banking, Financial Services, Citigroup

•••
•••
•••
•••

Pharmaceuticals Jobs

•••
•••
•••
•••